Yong Yi

2.5k total citations
68 papers, 2.0k citations indexed

About

Yong Yi is a scholar working on Oncology, Hepatology and Immunology. According to data from OpenAlex, Yong Yi has authored 68 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 22 papers in Hepatology and 20 papers in Immunology. Recurrent topics in Yong Yi's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Yong Yi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Yong Yi collaborates with scholars based in China, Ethiopia and United States. Yong Yi's co-authors include Jia Fan, Jian Zhou, Shuang–Jian Qiu, Jiaxing Wang, Xiaoyan Cai, Shuang‐Jian Qiu, Yi‐Peng Fu, Yunfeng Cheng, Hong-Wei He and Jian Sun and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Yong Yi

67 papers receiving 1.9k citations

Peers

Yong Yi
Tai Hato Japan
Masahiko Sakoda Japan
Qihan Fu China
Antonella Argentiero Italy
Ru Jia China
Yinan Deng China
Aurélie Hérault France
Ningling Ge China
Yutaka Kurebayashi Japan
Tai Hato Japan
Yong Yi
Citations per year, relative to Yong Yi Yong Yi (= 1×) peers Tai Hato

Countries citing papers authored by Yong Yi

Since Specialization
Citations

This map shows the geographic impact of Yong Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Yi more than expected).

Fields of papers citing papers by Yong Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Yi. The network helps show where Yong Yi may publish in the future.

Co-authorship network of co-authors of Yong Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Yi. A scholar is included among the top collaborators of Yong Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Yi. Yong Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Min, Xiangyu Gao, Shuang‐Jian Qiu, et al.. (2025). The Role of Post-Translational Modifications in Necroptosis. Biomolecules. 15(4). 549–549. 1 indexed citations
2.
Guan, Ruo‐Yu, Zhangfu Yang, Bao‐Ye Sun, et al.. (2024). Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis. Cancer Medicine. 13(23). e70459–e70459. 1 indexed citations
3.
Sun, Bao‐Ye, Zhu-Tao Wang, Yang Song, et al.. (2024). Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma. Cell Death Discovery. 10(1). 304–304. 10 indexed citations
4.
Weng, Jialei, Zheng Wang, Zhiqiu Hu, et al.. (2024). Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy. Cancer Research. 84(11). 1817–1833. 18 indexed citations
5.
Zhou, Cheng, Bao‐Ye Sun, Yong Yi, et al.. (2024). Peripheral Lymphocytes in Primary Liver Cancers: Elevated NK and CD8+ T Cells and Dysregulated Selenium Metabolism. Biomolecules. 14(2). 222–222. 5 indexed citations
6.
7.
Weng, Jialei, Shaoqing Liu, Qiang Zhou, et al.. (2023). Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 11(6). e006655–e006655. 32 indexed citations
8.
Zhou, Chenhao, Jialei Weng, Shaoqing Liu, et al.. (2023). Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA. Hepatology International. 17(6). 1461–1476. 3 indexed citations
9.
Guan, Ruo‐Yu, Bao‐Ye Sun, Zhu-Tao Wang, et al.. (2022). Antiviral therapy improves postoperative survival of patients with HBV-related hepatocellular carcinoma. The American Journal of Surgery. 224(1). 494–500. 5 indexed citations
10.
Liu, Gao, Zhangfu Yang, Jian Sun, et al.. (2022). The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth. Cellular Oncology. 45(6). 1435–1449. 17 indexed citations
11.
Liu, Gao, Jian Sun, Zhangfu Yang, et al.. (2021). Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death and Disease. 12(3). 260–260. 95 indexed citations
12.
Jing, Chuyu, Yi‐Peng Fu, Yong Yi, et al.. (2019). HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1. Journal for ImmunoTherapy of Cancer. 7(1). 77–77. 91 indexed citations
13.
14.
Fu, Yi‐Peng, Yong Yi, Xiaoyan Cai, et al.. (2016). Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection. British Journal of Cancer. 114(7). 767–776. 63 indexed citations
15.
Uddin, Sardar M.Z., Brendon Richbourgh, Yong Yi, & Liu C. (2015). Synergistic effects of progranulin and low intensity pulsed ultrasound on chondrocyte differentiation, migration and metabolism. Osteoarthritis and Cartilage. 23. A144–A145. 2 indexed citations
16.
Wang, Jiaxing, Yong Yi, Yiwei Li, et al.. (2014). Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection. BMC Cancer. 14(1). 297–297. 45 indexed citations
17.
Liao, Rui, Jian Sun, Han Wu, et al.. (2013). High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 32(1). 3–3. 144 indexed citations
18.
Gao, Qiang, Yingjun Zhao, Xiaoying Wang, et al.. (2012). CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma. Cancer Research. 72(14). 3546–3556. 136 indexed citations
19.
Gao, Qiang, Shuang‐Jian Qiu, Jian Zhou, et al.. (2012). B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunology Immunotherapy. 61(11). 2171–2182. 90 indexed citations
20.
Cui, Yan, Jiahong Dong, Jinlian Zhou, et al.. (2010). Effects of weightlessness on the apoptosis of hepatocytes in rats.. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 9(1). 52–54. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tai Hato Breakdown of academic impact, for papers by Masahiko Sakoda Breakdown of academic impact, for papers by Qihan Fu Breakdown of academic impact, for papers by Antonella Argentiero Breakdown of academic impact, for papers by Ru Jia Breakdown of academic impact, for papers by Yinan Deng Breakdown of academic impact, for papers by Aurélie Hérault Breakdown of academic impact, for papers by Ningling Ge Breakdown of academic impact, for papers by Yutaka Kurebayashi
Rankless by CCL
2026